Retatrutide is a novel triple agonist peptide under investigation for its role in modulating GLP-1, GIP, and glucagon receptors. Research has focused on its potential applications in obesity, metabolic regulation, and glucose control. Each vial contains 10mg of lyophilized peptide for in vitro and preclinical research.
For research use only. Not intended for human or veterinary use.
Retatrutide
$119.99 Regular Price
$99.99Sale Price